Ryman Healthcare Ltd (OTCPK:RYHTY)
$ 13.97 0 (0%) Market Cap: 1.92 Bil Enterprise Value: 3.43 Bil PE Ratio: 714.29 PB Ratio: 0.78 GF Score: 74/100

Half Year 2022 Ryman Healthcare Ltd Earnings Call Transcript

Nov 18, 2021 / 09:00PM GMT
Release Date Price: $52.66
David Kerr
Ryman Healthcare Limited - Independent Non-Executive Chairman of the Board

Good morning, everyone. It's nice to be with you all again, and welcome to Ryman Healthcare's results presentation for the 6 months to September 30, 2021.

My name is David Kerr, and I'm the Chair of Ryman Healthcare. And here with me in Christchurch, I have Richard Umbers, our newly appointed Group Chief Executive Officer; and David Bennett, our Group Chief Financial Officer, who many of you will know. On the line from Melbourne is Cameron Holland, the Chief Executive of our Australian business.

In a second, I'll hand over to Richard to give an overview of the result, and he will then hand over to David Bennett for further commentary. Dave will pass you over then to Cameron for an update on our progress in Australia. We welcome questions at the end. You can ask questions either online or over the phone. And of course, you can connect with us afterwards. Many of you have appointments made where we can have good one-on-one discussions. For those of you on the phone, our operator will advise when you're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot